Yaws epidemiology and demographics

Jump to navigation Jump to search

Yaws Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Yaws from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Yaws epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Yaws epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Yaws epidemiology and demographics

CDC on Yaws epidemiology and demographics

Yaws epidemiology and demographics in the news

Blogs on Yaws epidemiology and demographics

Directions to Hospitals Treating Yaws

Risk calculators and risk factors for Yaws epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Yaws mainly affects children in rural, warm, tropical areas, such as the Caribbean Islands, Latin America, West Africa, India, and Southeast Asia.

Epidemiology and Demographics

The disease is transmitted by skin contact with infected individuals or eye gnats, the spirochete entering through an existing cut or similar damage. Within ninety days (but usually less than a month) of infection a painless but distinctive 'mother yaw' ulcer appears. These tracts heal with keloid formation which can cause deformities, disabilities and limb contractures. The bone lesions caused are periostitis, osteitis, and osteomyelitis, damage to the tibia can lead to a condition known as sabre shins. In a very few cases a condition known as goundou is caused where growths on the nasal maxillae can result in extensive and severe damage to the nose and palate.

The largest group afflicted by yaws are children aged 6 to 10 years in tropical areas of the Americas, Africa, Asia or Oceania. There were World Health Organization funded campaigns against yaws from 1954 to 1963 which greatly reduced the incidence of the disease, although more recently numbers have risen again.

The disease is identified from blood tests or by a lesion sample through a darkfield examination under a microscope. Treatment is by a single dose of penicillin, erythromycin or tetracycline, recurrence or relapse is uncommon.

Examination of ancient remains has led to the suggestion that yaws has affected hominids for the last 1.5 million years. The current name is believed to be of Carib origin, "yaya" meaning sore; frambesia is a Modern Latin word inspired by the French word Pétasse ("raspberry").

Yaws was nearly eradicated by a worldwide treatment program in the 1950s, which reduced the number of sufferers of yaws from an estimated 50 million to nearly zero. However, the World Health Organization reported in January 2007 that yaws is on the rise again, with roughly a half a million sufferers, mostly in poor, rural areas.[1]

References

  1. "WHO: Flesh-Eating Disease Making Comeback". Associated Press. January 25, 2007. Retrieved 2007-01-25. Check date values in: |date= (help)



Template:WikiDoc Sources